×
Search

866-540-5505

Se Habla Espanol
Menu
Search

False Claims Act (Qui Tam) Representation

Home/Practice Areas/False Claims Act, Whistleblower & Qui Tam Matters/False Claims Act (Qui Tam) Representation

Understanding the False Claims Act

The False Claims Act (FCA) is the federal government’s primary tool for combating fraud involving taxpayer funds. It allows individuals, known as whistleblowers or relators, to bring lawsuits on behalf of the United States against those who knowingly submit false or fraudulent claims for payment to the government. These lawsuits, called qui tam actions, can result in significant recoveries for the government and monetary awards for whistleblowers who come forward with credible information.

Speak With a False Claims Act Attorney Today

History of the False Claims Act

The FCA traces its origins back to 1863, during the height of the Civil War. At that time, fraudulent billing and defective products plagued Union Army procurement. Suppliers charged the government for faulty rifles, diseased mules, and other substandard goods, draining public funds and undermining the war effort.

To address this widespread corruption, Congress passed the original False Claims Act in 1863, sometimes referred to as “Lincoln’s Law” after President Abraham Lincoln, who strongly supported the measure. The law encouraged private citizens to report fraud by allowing them to share in the government’s recovery. This qui tam provision was critical to empowering insiders to speak up.
Over the next century, the FCA remained on the books but was weakened in 1943 by amendments that reduced whistleblower rewards and barred suits based on information already in the government’s possession. These changes significantly limited the law’s effectiveness.

By the 1980s, concerns about defense contractor fraud—especially in relation to Pentagon spending—led Congress to strengthen the FCA. The 1986 amendments revitalized the statute by:

  • Increasing whistleblower rewards to 15–30% of the recovery
  • Adding strong anti-retaliation protections for whistleblowers
  • Broadening the definition of “knowing” conduct to include deliberate ignorance and reckless disregard
  • Increasing financial penalties and allowing for treble damages

The FCA has continued to evolve through further amendments in 2009, 2010, and 2016 that expanded its scope to cover additional types of fraud, strengthened protections, and clarified liability for retaining overpayments. Today, the FCA is widely recognized as one of the most effective anti-fraud laws in the world, responsible for returning tens of billions of dollars to the U.S. Treasury since its inception.

Key Provisions of the False Claims Act

Liability for False Claims

Liability arises when a person or company:

  • Knowingly submits false or fraudulent claims for payment or approval
  • Uses false statements to get a false claim paid
  • Improperly avoids returning money owed to the government

The term “knowingly” includes actual knowledge, deliberate ignorance, and reckless disregard—meaning willful blindness is no defense.

Whistleblower Rewards

Successful whistleblowers may receive 15–30% of the total government recovery. Factors that influence the percentage include:

  • The significance of the whistleblower’s contribution
  • Whether the government intervenes in the case
  • The extent to which the whistleblower participated in the fraud (reducing the award)

Rewards apply whether the recovery results from settlement or judgment.

Retaliation Protections

The FCA prohibits retaliation against employees, contractors, or agents who:

  • Report FCA violations
  • File a qui tam lawsuit
  • Participate in an FCA investigation

Prohibited retaliation includes termination, demotion, pay cuts, harassment, or blacklisting. Remedies for retaliation may include:

  • Reinstatement
  • Double back pay plus interest
  • Compensation for emotional distress

State False Claims Acts

In addition to the federal FCA, more than 30 states and the District of Columbia have enacted their own FCA statutes. These typically:

  • Apply to fraud involving state or local funds, most often Medicaid
  • Provide similar qui tam procedures and whistleblower rewards
  • Offer retaliation protections for whistleblowers

Some states, such as California, New York, and Illinois, have broader definitions of fraud and higher potential recoveries.

States with FCA statutes that meet federal requirements can receive an increased share of Medicaid fraud recoveries, incentivizing robust state enforcement.

How Whistleblower Cases Work

  1. Filing Under Seal – The whistleblower’s complaint is filed confidentially in federal court.
  2. Government Investigation – The DOJ or state attorney general investigates, often using subpoenas, data analysis, and witness interviews.
  3. Government Intervention Decision – Authorities decide whether to join the case or let the whistleblower proceed independently.
  4. Resolution – The case may be resolved through settlement, trial, or dismissal.
  5. Award Determination – If successful, the whistleblower receives a percentage of the recovery.

Miller Shah’s History

Miller Shah LLP’s attorneys have been involved in major FCA cases resulting in substantial recoveries, including:

  • Teva Pharmaceuticals – $54 million settlement resolving allegations of improper “speaker programs” to induce prescriptions in violation of the FCA and Anti‑Kickback Statute.
  • Booz Allen Hamilton – $377 million procurement fraud settlement, one of the largest FCA recoveries in DOJ history.
  • Caremark – In June 2025, a federal judge in Pennsylvania held Caremark liable for $95 million in Medicare overbilling related to generic drugs reimbursed by Walgreens and Rite Aid pharmacies.

Examples of False Claims Act Cases by Fraud Type

The False Claims Act has been applied across a wide range of industries, recovering billions of dollars for taxpayers. While healthcare and defense contracting account for some of the largest recoveries, the FCA can address any scheme involving false or fraudulent claims for government payment.

Below are common categories, examples of misconduct, and representative enforcement areas.

Customs and Import Duty Fraud

Importers can face FCA liability for making false statements to U.S. Customs and Border Protection to reduce or avoid import duties. Common misconduct includes:

  • Misclassification of Goods – Declaring products under incorrect tariff codes to secure lower duty rates.
  • Undervaluation of Shipments – Reporting artificially low values to reduce customs payments.
  • False Country of Origin Declarations – Misrepresenting the source of goods to avoid tariffs or comply with trade restrictions.

Cybersecurity and IT

Federal contractors and grantees may be liable under the FCA for failing to meet required cybersecurity or IT performance standards. Examples include:

  • Non‑Compliance with Cybersecurity Clauses – Misrepresenting compliance with Department of Defense or federal agency cybersecurity rules.
  • Falsified Security Certifications – Providing inaccurate attestations regarding system security, encryption, or monitoring.
  • Failure to Report Breaches – Omitting required breach disclosures to retain federal contracts or funding.

Defense Contractor Fraud

Defense procurement has historically been a major source of FCA recoveries. Common misconduct includes:

  • Overcharging for Goods or Services – Billing for inflated labor hours or materials.
  • Providing Defective or Non‑Conforming Products – Delivering goods that fail to meet contract specifications.
  • False Compliance Certifications – Misrepresenting adherence to military or contract requirements.

Education Fraud

Educational institutions receiving federal funding, such as Pell Grants or student loans, may face FCA liability for:

  • Falsifying Job Placement Rates – Misleading regulators and students about graduate employment outcomes.
  • Misrepresenting Accreditation – Claiming accreditation status that does not exist or has lapsed.
  • Enrolling Ineligible Students – Admitting students who do not meet eligibility criteria to access federal aid.

Environmental Fraud

Companies may violate the FCA by falsely certifying compliance with environmental laws or requirements tied to federal funding or contracts. Misconduct can include:

  • False Compliance Reporting – Misrepresenting pollution control, waste disposal, or emissions levels.
  • Improper Use of Federal Environmental Grants – Using funds for purposes unrelated to environmental protection.
  • Falsified Monitoring Data – Manipulating environmental testing results submitted to regulators.

Financial and Securities Fraud

Financial institutions and securities firms may face FCA claims for fraud tied to federally backed programs. Examples include:

  • Misrepresenting Loan Eligibility – Certifying that borrowers meet program requirements when they do not.
  • Mishandling Federally Guaranteed Funds – Misusing proceeds from government‑backed loans or investments.
  • False Certifications to Regulators – Misleading federal agencies about compliance with securities or banking regulations.

Government Grant and Research Fraud

Recipients of federal research or program grants may be liable under the FCA for:

  • Falsifying Research Results – Manipulating or fabricating data to maintain or secure funding.
  • Misusing Grant Funds – Spending federal funds on unrelated projects or unauthorized expenses.
  • False Progress Reporting – Misrepresenting milestones or deliverables to justify continued payments.

Healthcare Fraud

Healthcare fraud is the single largest source of FCA recoveries, often involving Medicare, Medicaid, and TRICARE billing.
Common examples include:

  • Upcoding and Unnecessary Services – Billing for higher‑paying procedures than those performed, or for services not medically necessary.
  • Kickbacks – Providing payments or other incentives to physicians or providers in exchange for patient referrals, in violation of the Anti‑Kickback Statute.
  • Billing for Non‑Existent Services – Submitting claims for care that was never provided.

Pharmaceutical and FDA

The FCA addresses fraud involving pharmaceuticals, medical devices, and related regulatory compliance. Examples include:

  • Off‑Label Marketing – Promoting drugs for uses not approved by the U.S. Food and Drug Administration (FDA).
  • Failure to Report Safety Data – Withholding adverse event reports or safety information from regulators.
  • Kickback Schemes – Paying prescribers or distributors to increase market share of a drug or device.

Procurement and Contract Fraud

Fraud in federal procurement can involve any industry receiving government contracts. Common forms include:

  • Overbilling for Labor or Materials – Charging for more resources than were actually used.
  • Substituting Non‑Compliant Products: Delivering cheaper goods that fail to meet specifications.
  • Falsifying Performance Certifications: Attesting to completion or compliance that has not been achieved.

Public Health and Pandemic Relief Fraud

The FCA has been a key enforcement tool for fraud related to COVID‑19 relief and other public health emergencies. Examples include:

  • Paycheck Protection Program (PPP) Abuse: Misrepresenting eligibility or use of funds for forgivable loans.
  • Provider Relief Fund Misuse: Spending emergency healthcare funds on unauthorized expenses.
  • False Reporting to Maintain Relief Funds: Misstating financial hardship or public health impacts to retain benefits.

Tax Fraud

While general tax fraud is outside FCA jurisdiction, certain tax‑related schemes tied to federal programs may trigger liability, such as:

  • False Tax Credit Claims: Misrepresenting eligibility for federally funded credit programs.
  • Misuse of Government Tax Incentives: Diverting funds received under a federal tax program to unauthorized purposes.

Frequently Asked Questions About the False Claims Act

What is a “false claim” under the FCA?

Any knowingly false request or statement made to obtain payment from the federal government.

Can anyone file an FCA lawsuit?

Generally, yes—any person with non-public evidence of fraud can file, though certain jurisdictional limits apply.

How much can whistleblowers recover?

Typically 15–30% of the government’s recovery.

Are whistleblowers protected from being fired?

Yes. The FCA and many state laws prohibit retaliation against whistleblowers.

Is there a deadline to file?

Most FCA cases must be filed within six years of the violation or within three years of when it was discovered.

Over 1 BILLION Recovered

Our team is equipped and prepared for complicated, high-stakes cases in all areas of business and civil litigation. We continuously strive to achieve the best possible results for our clients.

Novartis False Claims Act Settlement

$642 Million

Novartis False Claims Act Settlement
DST ERISA Class Action Settlement

$124.6 Million

DST ERISA Class Action Settlement
Teva False Claims Act Settlement

$54 Million

Teva False Claims Act Settlement
Norwegian Salmon Antitrust Settlement

$33 Million

Norwegian Salmon Antitrust Settlement
Virgin Airlines Wage and Hour Settlement

$31 Million

Virgin Airlines Wage and Hour Settlement
AMC Securities Settlement

$18 Million

AMC Securities Settlement
Eversource Energy ERISA Class Action Settlement

$14 Million

Eversource Energy ERISA Class Action Settlement
Universal Health Services ERISA Class Action Settlement

$12.5 Million

Universal Health Services ERISA Class Action Settlement
MedStar ERISA Class Action Settlement

$11.8 Million

MedStar ERISA Class Action Settlement
Safeway ERISA Class Action Settlement

$8.5 Million

Safeway ERISA Class Action Settlement
LinkedIn ERISA Class Action Settlement

$6.75 Million

LinkedIn ERISA Class Action Settlement
IQVIA Inc. ERISA Class Action Settlement

$3.5 Million

IQVIA Inc. ERISA Class Action Settlement
Coca-Cola ERISA Class Action Settlement

$3.5 Million

Coca-Cola ERISA Class Action Settlement
Beth Israel Medical ERISA Class Action Settlement

$2.9 Million

Beth Israel Medical ERISA Class Action Settlement
Rush University Medical ERISA Class Action Settlement

$2.9 Million

Rush University Medical ERISA Class Action Settlement
L Brands ERISA Class Action Settlement

$2.75 Million

L Brands ERISA Class Action Settlement
Omnicom ERISA Class Action Settlement

$2.45 Million

Omnicom ERISA Class Action Settlement

Words From Our Clients

Contact
Miller Shah LLP

While this website provides general information, it does not constitute legal advice. The best way to get guidance on your specific legal issue is to contact a lawyer. To schedule a meeting with an attorney, please call 866-540-5505 or complete the intake form to email us. To inquire about employment opportunities with Miller Shah LLP, please see our Opportunities page.
Alec J. Berin - Partners

PA Philadelphia | 866-540-5505

Alfonso Vilaboa - Partners

NY New York City | 866-540-5505

Ana Barba - Project Analyst

NY New York City | 866-540-5505

Anika S. Keuning - Project Analyst

NY New York City | 866-540-5505

Anna D’Agostino - Associate

NY New York City | 866-540-5505

Betsy Ferling-Hitriz - Legal Assistant

CT Chester | 866-540-5505

Bruce D. Parke - Partners

PA Philadelphia | 866-540-5505

Caroline Soper - Project Analyst

NY New York City | 866-540-5505

Christopher A. Miller - Associate

PA Philadelphia | 866-540-5505

Deborah C. England - Of Counsel

CA San Francisco | 866-540-5505

Elena M. DiBattista - Legal Assistant

FL Fort Lauderdale | 866-540-5505

Elise M. Wilson - Project Analyst

NY New York City | 866-540-5505

Eric L. Young - Of Counsel

PA Philadelphia | 866-540-5505

Gina S. Demetriades - Office Staff

CT Chester | 866-540-5505

Heidi A. Wendel - Of Counsel

NY New York City | 866-540-5505

Henry Fina - Project Analyst

PA Philadelphia | 866-540-5505

Isack Fadlon - Of Counsel

CA Los Angeles | 866-540-5505

James C. Shah - Partners

CA Los Angeles | 866-540-5505

James E. Miller - Partners

CT Chester | 866-540-5505

Jasmine Griswold - Legal Assistant

CT Chester | 866-540-5505

Jayne A. Goldstein - Partners

FL Fort Lauderdale | 866-540-5505

Jillian M. Lussier - Office Staff

CT Chester | 866-540-5505

Jocelyn McNamara - Law Clerk

NY New York City | 866-540-5505

Johanna C. Richter - Law Clerk

PA Philadelphia | 866-540-5505

Jonathan A. Dilger - Office Staff

NY New York City | 866-540-5505

Katie Edwards - Legal Assistant

PA Philadelphia | 866-540-5505

Kolin C. Tang - Partners

CA San Diego | 866-540-5505

Kyla Golding - Project Analyst

PA Philadelphia | 866-540-5505

Laurie Rubinow - Partners

CT Chester | 866-540-5505

Leanne Alvarado - Project Analyst

NY New York City | 866-540-5505

Madison A. Gregg - Associate

NY New York City | 866-540-5505

Mark Xiao - Associate

NY New York City | 866-540-5505

Matthew P. Suzor - Associate

PA Philadelphia | 866-540-5505

Natalie Finkelman Bennett - Partners

PA Philadelphia | 866-540-5505

Nathan C. Zipperian - Partners

FL Fort Lauderdale | 866-540-5505

Nicholas Day - Of Counsel

NJ Hoboken | 866-540-5505

Nicholas K. Ono - Project Analyst

NY New York City | 866-540-5505

Nicole Jefferson - Project Analyst

PA Philadelphia | 866-540-5505

Quintin C. Cerione - Project Analyst

PA Philadelphia | 866-540-5505

Robert W. Biela - Staff Attorney

PA Philadelphia | 866-540-5505

Rrita Osmani - Associate

CT Chester | 866-540-5505

Shuping Li - Law Clerk

NY New York City | 866-540-5505

Stephen T. Rutkowski - Law Clerk

CT Chester | 866-540-5505

Sue Moss - Legal Assistant

PA Philadelphia | 866-540-5505

Sydney D. Finlay - Associate

CA San Diego | 866-540-5505

Tara Gideon - Office Staff

PA Philadelphia | 866-540-5505

Tina Moukoulis - Staff Attorney

PA Philadelphia | 866-540-5505

Tracy Feldman - Office Staff

PA Philadelphia | 866-540-5505

Zacky P. Rozio - Of Counsel

CA Los Angeles | 310-203-0600